Takashi Umekawa
Stories by Takashi Umekawa
Japan’s Takeda forecasts $1.76b operating loss on Shire acquisition
The Shire acquisition catapulted Takeda into the world's top 10 drugmakers by sales but also made it one of the most indebted.
Japan’s Fujifilm to acquire Biogen’s subsidiary for about $890m
Through the acquisition, Fujifilm aims to achieve its 100 billion yen ($897.91 million) revenue target in its CDMO business by 2021.
Takeda Pharma unlikely to sell OTC drug business, says CEO
Takeda, whose $59-billion takeover of Shire will make it one of the world's most indebted pharma firms, plans to sell up to $10 billion in non-core as
Takeda gets Japanese approval for $62b Shire purchase
The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the Unite
Japanese pension fund GPIF continues push to pick foreign assets
The world's largest pension fund bought a net $6.9 billion of foreign assets during the quarter.
Japan should utilise dormant bank accounts for ‘impact investment’, says GSG chief
Laws covering Japanese utilization of dormant account funds for social causes were enacted in December 2016 and will come into effect by mid-2018.
